FdaApplication
BLA 125427
Identifiers
- fda_app_no: BLA125427
Properties
| Property | Value |
|---|---|
| applicant_name | Genentech, Inc. |
| application_type | BLA |
| approval_date | 2013-02-22 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| KADCYLA | ADO-TRASTUZUMAB EMTANSINE | 160MG | VIAL;SINGLE-USE |
| KADCYLA | ADO-TRASTUZUMAB EMTANSINE | 100MG | VIAL;SINGLE-USE |
2 products